Search results
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
KFGO· 4 days ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and...
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 4 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoDuring the March quarter, the U...projection. The company also raised its sales outlook for the...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 3 hours agoThe Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai,...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots |...
The State· 5 days agoSince last week, hundreds of social media posts and news stories have claimed that AstraZeneca is removing its COVID vaccine from the market after admitting ...
VDHP fines Salem CVS Pharmacy $75k for improper COVID-19 vaccine doses, drug theft, and expired...
WDBJ 7 Roanoke· 4 days agoThe DHP says a contract nurse, who was improperly trained in diluting and administering vaccines,...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 7 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 2 days agoNovavax is still developing a COVID-19/flu combination vaccine. It plans to start a phase 3 trial in...
Leaked Video of Mark Zuckerberg Discussing Vaccines Omits Context
Snopes via Yahoo News· 5 days agoAt the time, COVID-19 vaccines were months away from becoming available to the public. More...
3 High-Yield Dividend Stocks I'm Buying Hand Over Fist
Motley Fool via Yahoo Finance· 1 day agoPfizer is also well-known for its vaccines. The company's impressive lineup of products generates...